microRNA‐29a Regulates ADAM12 Through Direct Interaction With ADAM12 mRNA and Modulates Postischemic Perfusion Recovery

Background Peripheral artery disease is caused by atherosclerotic occlusion of vessels outside the heart and most commonly affects vessels of the lower extremities. Angiogenesis is a part of the postischemic adaptation involved in restoring blood flow in peripheral artery disease. Previously, in a m...

Full description

Bibliographic Details
Main Authors: Victor Lamin, Joseph Verry, Olumayowa S. Dokun, Ana Kronemberger, Thomas Wong, Vitor A. Lira, Ayotunde O. Dokun
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.025727
_version_ 1811215175284424704
author Victor Lamin
Joseph Verry
Olumayowa S. Dokun
Ana Kronemberger
Thomas Wong
Vitor A. Lira
Ayotunde O. Dokun
author_facet Victor Lamin
Joseph Verry
Olumayowa S. Dokun
Ana Kronemberger
Thomas Wong
Vitor A. Lira
Ayotunde O. Dokun
author_sort Victor Lamin
collection DOAJ
description Background Peripheral artery disease is caused by atherosclerotic occlusion of vessels outside the heart and most commonly affects vessels of the lower extremities. Angiogenesis is a part of the postischemic adaptation involved in restoring blood flow in peripheral artery disease. Previously, in a murine hind limb ischemia model of peripheral artery disease, we identified ADAM12 (a disintegrin and metalloproteinase gene 12) as a key genetic modifier of postischemic perfusion recovery. However, less is known about ADAM12 regulation in ischemia. MicroRNAs are a class of small, noncoding, single‐stranded RNAs that regulate gene expression primarily through transcriptional repression of messenger RNA (mRNA). We showed microRNA‐29a (miR‐29a) modulates ADAM12 expression in the setting of diabetes and ischemia. However, how miR‐29a modulates ADAM12 is not known. Moreover, the physiological effects of miR‐29a modulation in a nondiabetic setting is not known. Methods and Results We overexpressed or inhibited miR‐29a in ischemic mouse gastrocnemius and tibialis anterior muscles, and quantified the effect on perfusion recovery, ADAM12 expression, angiogenesis, and skeletal muscle regeneration. In addition, using RNA immunoprecipitation–based anti‐miR competitive assay, we investigated the interaction of miR‐29a and ADAM12 mRNA in mouse microvascular endothelial cell, skeletal muscle, and human endothelial cell lysates. Ectopic expression of miR‐29a in ischemic mouse hind limbs decreased ADAM12 mRNA expression, increased skeletal muscle injury, decreased skeletal muscle function, and decreased angiogenesis and perfusion recovery, with no effect on skeletal muscle regeneration and myofiber cross‐sectional area following hind limb ischemia. RNA immunoprecipitation–based anti‐miR competitive assay studies showed miR‐29a antagomir displaced miR‐29a and ADAM12 mRNA from the AGO‐2 (Argonaut‐2) complex in a dose dependent manner. Conclusions Taken together, the data show miR‐29a suppresses ADAM12 expression by directly binding to its mRNA, resulting in impaired skeletal muscle function, angiogenesis, and poor perfusion. Hence, elevated levels of miR‐29a, as seen in diabetes and aging, likely contribute to vascular pathology, and modulation of miR‐29a could be a therapeutic target.
first_indexed 2024-04-12T06:17:35Z
format Article
id doaj.art-dc2f88d9f651400888d2476a78f60cc3
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-04-12T06:17:35Z
publishDate 2022-08-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-dc2f88d9f651400888d2476a78f60cc32022-12-22T03:44:25ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802022-08-01111610.1161/JAHA.122.025727microRNA‐29a Regulates ADAM12 Through Direct Interaction With ADAM12 mRNA and Modulates Postischemic Perfusion RecoveryVictor Lamin0Joseph Verry1Olumayowa S. Dokun2Ana Kronemberger3Thomas Wong4Vitor A. Lira5Ayotunde O. Dokun6Division of Endocrinology and Metabolism, Carver College of Medicine University of Iowa Iowa City IADivision of Endocrinology and Metabolism, Carver College of Medicine University of Iowa Iowa City IADivision of Endocrinology and Metabolism, Carver College of Medicine University of Iowa Iowa City IAFraternal Order of Eagles Diabetes Research Center, Carver College of Medicine University of Iowa Iowa City IADivision of Endocrinology and Metabolism, Carver College of Medicine University of Iowa Iowa City IAFraternal Order of Eagles Diabetes Research Center, Carver College of Medicine University of Iowa Iowa City IADivision of Endocrinology and Metabolism, Carver College of Medicine University of Iowa Iowa City IABackground Peripheral artery disease is caused by atherosclerotic occlusion of vessels outside the heart and most commonly affects vessels of the lower extremities. Angiogenesis is a part of the postischemic adaptation involved in restoring blood flow in peripheral artery disease. Previously, in a murine hind limb ischemia model of peripheral artery disease, we identified ADAM12 (a disintegrin and metalloproteinase gene 12) as a key genetic modifier of postischemic perfusion recovery. However, less is known about ADAM12 regulation in ischemia. MicroRNAs are a class of small, noncoding, single‐stranded RNAs that regulate gene expression primarily through transcriptional repression of messenger RNA (mRNA). We showed microRNA‐29a (miR‐29a) modulates ADAM12 expression in the setting of diabetes and ischemia. However, how miR‐29a modulates ADAM12 is not known. Moreover, the physiological effects of miR‐29a modulation in a nondiabetic setting is not known. Methods and Results We overexpressed or inhibited miR‐29a in ischemic mouse gastrocnemius and tibialis anterior muscles, and quantified the effect on perfusion recovery, ADAM12 expression, angiogenesis, and skeletal muscle regeneration. In addition, using RNA immunoprecipitation–based anti‐miR competitive assay, we investigated the interaction of miR‐29a and ADAM12 mRNA in mouse microvascular endothelial cell, skeletal muscle, and human endothelial cell lysates. Ectopic expression of miR‐29a in ischemic mouse hind limbs decreased ADAM12 mRNA expression, increased skeletal muscle injury, decreased skeletal muscle function, and decreased angiogenesis and perfusion recovery, with no effect on skeletal muscle regeneration and myofiber cross‐sectional area following hind limb ischemia. RNA immunoprecipitation–based anti‐miR competitive assay studies showed miR‐29a antagomir displaced miR‐29a and ADAM12 mRNA from the AGO‐2 (Argonaut‐2) complex in a dose dependent manner. Conclusions Taken together, the data show miR‐29a suppresses ADAM12 expression by directly binding to its mRNA, resulting in impaired skeletal muscle function, angiogenesis, and poor perfusion. Hence, elevated levels of miR‐29a, as seen in diabetes and aging, likely contribute to vascular pathology, and modulation of miR‐29a could be a therapeutic target.https://www.ahajournals.org/doi/10.1161/JAHA.122.025727ADAM12angiogenesishind limb ischemiamiR‐29a and peripheral artery disease
spellingShingle Victor Lamin
Joseph Verry
Olumayowa S. Dokun
Ana Kronemberger
Thomas Wong
Vitor A. Lira
Ayotunde O. Dokun
microRNA‐29a Regulates ADAM12 Through Direct Interaction With ADAM12 mRNA and Modulates Postischemic Perfusion Recovery
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
ADAM12
angiogenesis
hind limb ischemia
miR‐29a and peripheral artery disease
title microRNA‐29a Regulates ADAM12 Through Direct Interaction With ADAM12 mRNA and Modulates Postischemic Perfusion Recovery
title_full microRNA‐29a Regulates ADAM12 Through Direct Interaction With ADAM12 mRNA and Modulates Postischemic Perfusion Recovery
title_fullStr microRNA‐29a Regulates ADAM12 Through Direct Interaction With ADAM12 mRNA and Modulates Postischemic Perfusion Recovery
title_full_unstemmed microRNA‐29a Regulates ADAM12 Through Direct Interaction With ADAM12 mRNA and Modulates Postischemic Perfusion Recovery
title_short microRNA‐29a Regulates ADAM12 Through Direct Interaction With ADAM12 mRNA and Modulates Postischemic Perfusion Recovery
title_sort microrna 29a regulates adam12 through direct interaction with adam12 mrna and modulates postischemic perfusion recovery
topic ADAM12
angiogenesis
hind limb ischemia
miR‐29a and peripheral artery disease
url https://www.ahajournals.org/doi/10.1161/JAHA.122.025727
work_keys_str_mv AT victorlamin microrna29aregulatesadam12throughdirectinteractionwithadam12mrnaandmodulatespostischemicperfusionrecovery
AT josephverry microrna29aregulatesadam12throughdirectinteractionwithadam12mrnaandmodulatespostischemicperfusionrecovery
AT olumayowasdokun microrna29aregulatesadam12throughdirectinteractionwithadam12mrnaandmodulatespostischemicperfusionrecovery
AT anakronemberger microrna29aregulatesadam12throughdirectinteractionwithadam12mrnaandmodulatespostischemicperfusionrecovery
AT thomaswong microrna29aregulatesadam12throughdirectinteractionwithadam12mrnaandmodulatespostischemicperfusionrecovery
AT vitoralira microrna29aregulatesadam12throughdirectinteractionwithadam12mrnaandmodulatespostischemicperfusionrecovery
AT ayotundeodokun microrna29aregulatesadam12throughdirectinteractionwithadam12mrnaandmodulatespostischemicperfusionrecovery